Clinical trials are studies on people to determine whether a new treatment—like an experimental drug or medical device—is safe and effective. One clinical trial might investigate whether a new treatment is more effective than the current standard care. At the same time, another might focus on finding potential treatments before any symptoms present.
As reviewed at the Health 2.0 Conference’s USA edition, clinical trials also help determine what makes life better for patients suffering from chronic illnesses or terminal diseases; one example would be improving quality of life through pain relief and minimizing discomfort during treatments.
Establishing a marketing plan at the onset is vital when starting any business. Identifying customer wants and needs is essential so that future marketing or advertising efforts are focused, which increases the odds of success.
The United States and Europe have historically dominated the market, but as the Asia Pacific region emerges as a market leader, this may change in the coming years.
Following the pandemic, the post-COVID healthcare events in the USA highlighted the importance of clinical trials. As governments attempted to control the rising number of cases, the scientific community lent its support by developing vaccines in record time. Large-scale clinical trials were conducted worldwide to approve the vaccines for emergency use. This has not only demonstrated the importance of innovation in clinical trials, but it has also resulted in market changes.
According to experts from top healthcare conferences, the most significant change in the industry since the 1990s has been complete digitization, which has eliminated paper use. This is a substantial accomplishment in centralizing systems, streamlining processes, and effectively managing data.
Clinical trials are carried out in four stages:
Stage I involves safety testing, stage II involves efficacy testing, stage III involves absolute protection and efficacy testing, and stage IV involves post-purchase research.
Technology is expected to drive some of the most significant changes in the clinical trials industry over the next few years. Digital platforms and intelligent applications will be used to obtain informed consent from participants, store data, and perform other critical tasks. Another tool that has recently gained popularity is electronic patient-reported outcomes (ePRO). Using the ePRO system, patients can use electronic devices to fill out and submit information about their symptoms, side effects, drug administration, and other topics.
Finally, in terms of CAGR, the Asia Pacific region has been the fastest-growing market for clinical trials. This increase has been attributed to emerging economies, an expanding healthcare sector, and uniform legislation.
Overall, we look forward to many significant changes in 2022-23. These changes will aid in advancing the clinical trials industry, propelling us toward solving more complex problems. 2022 US healthcare events, like the Health 2.0 Conference, will also play an essential role in experts figuring out clinical trial trends more efficiently.
Sarika Gautam is one of the proud leads of the Health 2.0 Conference Dubai edition. The three-day conference is a hotspot of healthcare professionals, medical practitioners, and C-suite executives. Health 2.0 Conference’s upcoming edition is ready to explore interesting topics like digital therapeutics and why including fraud, scam, and spam prevention tactics is the need of the hour.
